NF-κ B Promotes Breast Cancer Cell Migration and Metastasis by Inducing the Expression of the Chemokine Receptor CXCR4

Involvement of chemokine receptors in breast cancer metastasis

Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340 · see citing works

Function and Activation of NF-kappaB in the Immune System

Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745 · see citing works

Cellular survival: a play in three Akts

Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216 · see citing works

NF-κB in cancer: from innocent bystander to major culprit

Karin, M., Cao, Y., Greten, F. R., & Li, Z. (2002) · Nature reviews. Cancer · doi:10.1038/nrc780 · Cited by 2,476 · see citing works

Changing views of the role of matrix metalloproteinases in metastasis

Chambers, A. F., & Matrisian, L. M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.17.1260 · Cited by 1,597 · see citing works

Constitutive Activation of NF-κB during Progression of Breast Cancer to Hormone-Independent Growth

Nakshatri, H., Bhat‐Nakshatri, P., Martin, D. A., Goulet, R. J., & Sledge, G. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3629 · Cited by 818 · see citing works

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.

Bargou, R. C., Emmerich, F., Krappmann, D., Bommert, K., Mapara, M. Y., Arnold, W., Royer, H., Grinstein, E., Greiner, A., Scheidereit, C., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119849 · Cited by 757 · see citing works

Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.

Sovak, M. A., Bellas, R. E., Kim, D. W., Zanieski, G., Rogers, A. E., Traish, A. M., & Sonenshein, G. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119848 · Cited by 720 · see citing works

Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells.

Sato, H., & Seiki, M. (1993) · PubMed · Cited by 701 · see citing works

The α-Chemokine, Stromal Cell-derived Factor-1α, Binds to the Transmembrane G-protein-coupled CXCR-4 Receptor and Activates Multiple Signal Transduction Pathways

Ganju, R. K., Brubaker, S. A., Meyer, J., Dutt, P., Yang, Y., Qin, S., Newman, W., & Groopman, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.36.23169 · Cited by 614 · see citing works

Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.

Scotton, C. J., Wilson, J. L., Scott, K. A., Stamp, G., Wilbanks, G. D., Fricker, S. P., Bridger, G. J., & Balkwill, F. R. (2002) · PubMed · Cited by 476 · see citing works

Selective activation of NF-κB subunits in human breast cancer: potential roles for NF-κB2/p52 and for Bcl-3

Cogswell, P. C., D, D. C. G., Funkhouser, W. K., & Baldwin, A. S. (2000) · Oncogene · doi:10.1038/sj.onc.1203412 · Cited by 452 · see citing works

Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4.

Bachelder, R. E., Wendt, M. A., & Mercurio, A. M. (2002) · PubMed · Cited by 428 · see citing works

Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression.

Koshiba, T., Hosotani, R., Miyamoto, Y., Ida, J., Tsuji, S., Nakajima, S., Kawaguchi, M., Kobayashi, H., Doi, R., Hori, T., et al. (2000) · PubMed · Cited by 427 · see citing works

A requirement for NF-kappa B activation in Bcr-Abl-mediated transformationPreprint

Reuther, J. Y., Reuther, G. W., Cortez, D., Pendergast, A. M., & Baldwin, A. S. (1998) · Genes & Development · doi:10.1101/gad.12.7.968 · Cited by 392 · see citing works

The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex.

Hehner, S. P., Hofmann, T. G., Dröge, W., & Schmitz, M. L. (1999) · PubMed · Cited by 386 · see citing works

Development of the Proteasome Inhibitor PS-341

Adams, J. (2002) · The Oncologist · doi:10.1634/theoncologist.7-1-9 · Cited by 376 · see citing works

The Antiinflammatory Sesquiterpene Lactone Parthenolide Inhibits NF-κB by Targeting the IκB Kinase Complex

Hehner, S. P., Hofmann, T. G., Dröge, W., & Schmitz, M. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5617 · Cited by 356 · see citing works

Epidermal growth factor-induced nuclear factor κB activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells

Biswas, D. K., Cruz, A. P., Gansberger, E., & Pardee, A. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.15.8542 · Cited by 353 · see citing works

Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells.

Murakami, T., Maki, W. C., Cardones, A. R., Fang, H., Tun-Kyi, A., Nestle, F. O., & Hwang, S. T. (2002) · PubMed · Cited by 347 · see citing works

Paclitaxel sensitivity of breast cancer cells with constitutively active NF-κB is enhanced by IκBα super-repressor and parthenolide

Patel, N. M., Nozaki, S., Shortle, N. H., Bhat‐Nakshatri, P., Newton, T. R., Rice, S. E., Gelfanov, V. M., Boswell, S. H., Goulet, R. J., Sledge, G. W., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203768 · Cited by 294 · see citing works

The SDF‐1‐CXCR4 Axis Stimulates VEGF Secretion and Activates Integrins but does not Affect Proliferation and Survival in Lymphohematopoietic Cells

Kijowski, J., Baj‐Krzyworzeka, M., Majka, M., Reca, R., Marquez‐Curtis, L. A., Christofidou‐Solomidou, M., Janowska‐Wieczorek, A., & Ratajczak, M. Z. (2001) · Stem Cells · doi:10.1634/stemcells.19-5-453 · Cited by 224 · see citing works

An attractive force in metastasis

Liotta, L. A. (2001) · Nature · doi:10.1038/35065180 · Cited by 185 · see citing works

Inhibition of NF-κB Activity Decreases the VEGF mRNA Expression in MDA-MB-231 Breast Cancer Cells

Shibata, A., Nagaya, T., Imai, T., Funahashi, H., Nakao, A., & Seo, H. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1015872531675 · Cited by 168 · see citing works

A novel complex between the p65 subunit of NF‐kappa B and c‐Rel binds to a DNA element involved in the phorbol ester induction of the human urokinase gene.

Hansen, S. K., Nerlov, C., Zabel, U., Verde, P., Johnsen, M., Baeuerle, P. A., & Blasi, F. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05043.x · Cited by 164 · see citing works

The host environment promotes the constitutive activation of nuclear factor-kappaB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma.

Dong, G., Chen, Z., Kato, T., & Waes, C. V. (1999) · PubMed · Cited by 149 · see citing works

Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor kappaB.

Andela, V. B., Schwarz, E. M., Puzas, J. E., O’Keefe, R. J., & Rosier, R. N. (2000) · PubMed · Cited by 149 · see citing works

Enhancement of intracellular signaling associated with hematopoietic progenitor cell survival in response to SDF-1/CXCL12 in synergy with other cytokines

Lee, Y., Gotoh, A., Kwon, H., You, M., Kohli, L. L., Mantel, C., Cooper, S. H., Hangoc, G., Miyazawa, K., Ohyashiki, K., et al. (2002) · Blood · doi:10.1182/blood.v99.12.4307 · Cited by 147 · see citing works

Enhanced degradation of I-kappaB alpha contributes to endogenous activation of NF-kappaB in Hs294T melanoma cells.

Shattuck-Brandt, R. L., & Richmond, A. (1997) · PubMed · Cited by 142 · see citing works

Proteases — invasion and more

Edwards, D. R., & Murphy, G. (1998) · Nature · doi:10.1038/28961 · Cited by 138 · see citing works

The role of chemoattraction in cancer metastases

Moore, M. A. S. (2001) · BioEssays · doi:10.1002/bies.1095 · Cited by 138 · see citing works

Phosphatidylinositol 3-Kinase and NF-κB Regulate Motility of Invasive MDA-MB-231 Human Breast Cancer Cells by the Secretion of Urokinase-type Plasminogen Activator

Slíva, D., Rizzo, M. T., & English, D. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109579200 · Cited by 134 · see citing works

Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis

Nicolson, G. L. (1993) · Cancer and Metastasis Reviews · doi:10.1007/bf00665961 · Cited by 130 · see citing works

Genomic organization and promoter characterization of human CXCR4 gene1

Carúz, A., Samsom, M., Alonso, J. M., Alcamı́, J., Baleux, F., Virelizier, J. L., Parmentier, M., & Arenzana‐Seisdedos, F. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00359-7 · Cited by 116 · see citing works

Identification of signal transduction pathways involved in constitutive NF-κB activation in breast cancer cells

Bhat‐Nakshatri, P., Sweeney, C. J., & Nakshatri, H. (2002) · Oncogene · doi:10.1038/sj.onc.1205243 · Cited by 115 · see citing works

NF-κB activation and interleukin 6 production in fibroblasts by estrogen receptor-negative breast cancer cell-derived interleukin 1α

Bhat‐Nakshatri, P., Newton, T. R., Goulet, R. J., & Nakshatri, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6971 · Cited by 90 · see citing works

Cancer Cell-Derived Interleukin 1α Contributes to Autocrine and Paracrine Induction of Pro-metastatic Genes in Breast Cancer

Nozaki, S., Sledge, G. W., & Nakshatri, H. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3241 · Cited by 79 · see citing works

NF-κB and breast cancer

Nakshatri, H., & Goulet, R. J. (2002) · Current Problems in Cancer · doi:10.1067/mcn.2002.129977 · Cited by 68 · see citing works

Negative Regulation of Transactivation Function but Not DNA Binding of NF-κB and AP-1 by IκBβ1 in Breast Cancer Cells

Newton, T. R., Patel, N. M., Bhat‐Nakshatri, P., Stauss, C. R., Goulet, R. J., & Nakshatri, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18827 · Cited by 64 · see citing works

Molecular characterization of CXCR–4: A potential brain tumor-associated gene

Sehgal, A., Ricks, S., Boynton, A. L., Warrick, J., & Murphy, G. P. (1998) · Journal of Surgical Oncology · doi:10.1002/(sici)1096-9098(199812)69:4 · Cited by 64 · see citing works

CD30 triggering by agonistic antibodies regulates CXCR4 expression and CXCL12 chemotactic activity in the cell line L540

Vinante, F., Rigo, A., Scupoli, M. T., & Pizzolo, G. (2002) · Blood · doi:10.1182/blood.v99.1.52 · Cited by 25 · see citing works

Transgenic overexpression of the CC chemokine CCL21 disrupts T-cell migration

Christopherson, K. W., Campbell, J. J., & Hromas, R. (2001) · Blood · doi:10.1182/blood.v98.13.3562 · Cited by 23 · see citing works

Cancer and the chemokine network

Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343 · see citing works

Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy

Nagarsheth, N., Wicha, M. S., & Zou, W. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.49 · Cited by 2,217 · see citing works

Nuclear factor-κB: The enemy within

Aggarwal, B. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.003 · Cited by 1,289 · see citing works

Tumor Self-Seeding by Circulating Cancer Cells

Kim, M.-Y., Oskarsson, T., Acharyya, S., Nguyen, D. X., Zhang, X. H.-F., Norton, L., & Massagué, J. (2009) · Cell · doi:10.1016/j.cell.2009.11.025 · Cited by 1,335 · see citing works

Inflammation and cancer: how hot is the link?

Aggarwal, B. B., Shishodia, S., Sandur, S. K., Pandey, M. K., & Sethi, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.029 · Cited by 1,312 · see citing works

Anoikis molecular pathways and its role in cancer progression

Paoli, P., Giannoni, E., & Chiarugi, P. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.06.026 · Cited by 1,160 · see citing works

Role of interleukin-6 in cancer progression and therapeutic resistance

Kumari, N., Dwarakanath, B. S. R., Das, A., & Bhatt, A. N. (2016) · Tumor Biology · doi:10.1007/s13277-016-5098-7 · Cited by 1,096 · see citing works

NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression

Huber, M. A., Azoitei, N., Baumann, B., Grünert, S., Sommer, A., Pehamberger, H., Kraut, N., Beug, H., & Wirth, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21358 · Cited by 1,035 · see citing works

CD44+/CD24-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis

Sheridan, C. A., Kishimoto, H., Fuchs, R. K., Mehrotra, S., Bhat‐Nakshatri, P., Turner, C. H., Goulet, R. J., Badve, S., & Nakshatri, H. (2006) · Breast Cancer Research · doi:10.1186/bcr1610 · Cited by 995 · see citing works

Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe

Aggarwal, B. B., Vijayalekshmi, R. V., & Sung, B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0149 · Cited by 795 · see citing works

NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer

Fan, Y., Mao, R., & Yang, J. (2013) · Protein & Cell · doi:10.1007/s13238-013-2084-3 · Cited by 779 · see citing works

Trafficking of Normal Stem Cells and Metastasis of Cancer Stem Cells Involve Similar Mechanisms: Pivotal Role of the SDF‐1–CXCR4 Axis

Kucia, M., Reca, R., Miękus, K., Wanzeck, J., Wojakowski, W., Janowska‐Wieczorek, A., Ratajczak, J., & Ratajczak, M. Z. (2005) · Stem Cells · doi:10.1634/stemcells.2004-0342 · Cited by 761 · see citing works

The significance of cancer cell expression of the chemokine receptor CXCR4

Balkwill, F. R. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.10.003 · Cited by 759 · see citing works

CXCR4 Regulates Growth of Both Primary and Metastatic Breast Cancer

Smith, M. C. P., Luker, K. E., Garbow, J. R., Prior, J. L., Jackson, E. N., Piwnica-Worms, D. R., & Luker, G. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1844 · Cited by 715 · see citing works

CXCR4–SDF-1 Signalling, Locomotion, Chemotaxis and Adhesion

Kucia, M., Jankowski, K., Reca, R., Wysoczynski, M., Bandura‐Morgan, L., Allendorf, D. J., Zhang, J., Ratajczak, J., & Ratajczak, M. Z. (2004) · Journal of Molecular Histology · doi:10.1023/b:hijo.0000032355.66152.b8 · Cited by 698 · see citing works

Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways

Schetter, A. J., Heegaard, N. H. H., & Harris, C. C. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp272 · Cited by 659 · see citing works

Regulation of CXCR4 signaling

Busillo, J. M., & Benovic, J. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.11.002 · Cited by 617 · see citing works

A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors

Rubin, J. B., Kung, A. L., Klein, R. S., Chan, J. A.-W., Sun, Y., Schmidt, K. F., Kieran, M. W., Luster, A. D., & Segal, R. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235846100 · Cited by 615 · see citing works

Transcriptional profiling of the LPS induced NF-κB response in macrophages

Sharif, O., Bolshakov, V. N., Raines, S., Newham, P., & Perkins, N. D. (2007) · BMC Immunology · doi:10.1186/1471-2172-8-1 · Cited by 500 · see citing works

Toll-Like Receptors on Human Mesenchymal Stem Cells Drive Their Migration and Immunomodulating Responses

Tomchuck, S. L., Zwezdaryk, K. J., Coffelt, S. B., Waterman, R. S., Danka, E. S., & Scandurro, A. B. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0563 · Cited by 449 · see citing works

Macrophages Induce Invasiveness of Epithelial Cancer Cells Via NF-κB and JNK

Hagemann, T., Wilson, J. L., Kulbe, H., Li, N. F., Leinster, D. A., Charles, K. A., Klemm, F., Pukrop, T., Binder, C. R., & Balkwill, F. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.1197 · Cited by 433 · see citing works

The pleiotropic effects of the SDF-1–CXCR4 axis in organogenesis, regeneration and tumorigenesis

Ratajczak, M. Z., Zuba‐Surma, E. K., Kucia, M., Reca, R., Wojakowski, W., & Ratajczak, J. (2006) · Leukemia · doi:10.1038/sj.leu.2404357 · Cited by 423 · see citing works

Nuclear Factor-κB Activation: From Bench to Bedside

Sethi, G., Sung, B., & Aggarwal, B. B. (2008) · Experimental Biology and Medicine · doi:10.3181/0707-mr-196 · Cited by 417 · see citing works

The chemokine system and cancer

Balkwill, F. R. (2011) · The Journal of Pathology · doi:10.1002/path.3029 · Cited by 414 · see citing works

CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer

Mori, T., Doi, R., Koizumi, M., Toyoda, E., Ito, D., Kami, K., Masui, T., Fujimoto, K., Tamamura, H., Hiramatsu, K., et al. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.29.3.1 · Cited by 407 · see citing works

Context-Specific Regulation of NF-κB Target Gene Expression by EZH2 in Breast Cancers

Lee, S. T., Li, Z., Wu, Z., Aau, M., Guan, P., Karuturi, R. K. M., Liou, Y. C., & Yu, Q. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.011 · Cited by 397 · see citing works

Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis

Kryczek, I., Wei, S., Keller, E. T., Liu, R., & Zou, W. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00406.2006 · Cited by 329 · see citing works

Inflammation: A driving force speeds cancer metastasis

Wu, Y., & Zhou, B. P. (2009) · Cell Cycle · doi:10.4161/cc.8.20.9699 · Cited by 327 · see citing works

The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer

Masjedi, A., Hashemi, V., Hojjat-Farsangi, M., Ghalamfarsa, G., Azizi, G., Yousefi, M., & Jadidi-Niaragh, F. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.177 · Cited by 303 · see citing works

Breast cancer lung metastasis: Molecular biology and therapeutic implications

Jin, L., Han, B., Siegel, E. L., Cui, Y., Giuliano, A. E., & Cui, X. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1456599 · Cited by 298 · see citing works

Control of cell migration in the development of the posterior lateral line: antagonistic interactions between the chemokine receptors CXCR4 and CXCR7/RDC1

Dambly‐Chaudière, C., Cubedo, N., & Ghysen, A. (2007) · BMC Developmental Biology · doi:10.1186/1471-213x-7-23 · Cited by 297 · see citing works

Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment

O’Hayre, M., Salanga, C. L., Handel, T. M., & Allen, S. J. (2008) · Biochemical Journal · doi:10.1042/bj20071493 · Cited by 297 · see citing works

CXCR4 and cancer

Furusato, B., Mohamed, A. A. M., Uhlén, M., & Rhim, J. S. (2010) · Pathology International · doi:10.1111/j.1440-1827.2010.02548.x · Cited by 295 · see citing works

Functions of CXCL12 and CXCR4 in breast cancer

Luker, K. E., & Luker, G. D. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.06.021 · Cited by 288 · see citing works

Transcription factors control invasion: AP-1 the first among equals

Ozanne, B. W., Spence, H. J., McGarry, L., & Hennigan, R. F. (2006) · Oncogene · doi:10.1038/sj.onc.1209759 · Cited by 287 · see citing works

Targeting the NFκB Signaling Pathways for Breast Cancer Prevention and Therapy

Wang, W., Nag, S. A., & Zhang, R. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666141106124315 · Cited by 280 · see citing works

Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells.

Lee, B.-C., Lee, T.-H., Avraham, S., & Avraham, H. K. (2004) · PubMed · Cited by 281 · see citing works

Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy

Zhou, W., Guo, S., Liu, M., Burow, M. E., & Wang, G. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170830111531 · Cited by 279 · see citing works

Cross-talk between Paracrine-Acting Cytokine and Chemokine Pathways Promotes Malignancy in Benign Human Prostatic Epithelium

Ao, M., Franco, O. E., Park, D., Raman, D., Williams, K., & Hayward, S. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3946 · Cited by 276 · see citing works

NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy

Shen, H., & Tergaonkar, V. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0315-0 · Cited by 278 · see citing works

MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways

Keklikoglou, I., Körner, C., Schmidt, C., Zhang, J. D., Heckmann, D., Shavinskaya, A., Allgayer, H., Gückel, B., Fehm, T. N., Schneeweiß, A., et al. (2011) · Oncogene · doi:10.1038/onc.2011.571 · Cited by 273 · see citing works

Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma

Kato, M., Kitayama, J., Kazama, S., & Nagawa, H. (2003) · Breast Cancer Research · doi:10.1186/bcr627 · Cited by 267 · see citing works

Organ selectivity in metastasis: regulation by chemokines and their receptors

Ben‐Baruch, A. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9097-3 · Cited by 264 · see citing works

The NF-κB Pathway and Cancer Stem Cells

Rinkenbaugh, A. L., & Baldwin, A. S. (2016) · Cells · doi:10.3390/cells5020016 · Cited by 265 · see citing works

Effect of Chemokine Receptors CXCR4 and CCR7 on the Metastatic Behavior of Human Colorectal Cancer

Schimanski, C. C., Schwald, S., Simiantonaki, N., Jayasinghe, C., Gönner, U., Wilsberg, V., Junginger, T., Berger, M. R., Galle, P. R., & Moehler, M. H. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1195 · Cited by 257 · see citing works

Emerging targets in cancer management: role of the CXCL12/CXCR4 axis

Dubrovska, A., Cojoc, M., Peitzsch, C., Trautmann, F., Polishchuk, & Telegeev (2013) · OncoTargets and Therapy · doi:10.2147/ott.s36109 · Cited by 255 · see citing works

Reduction of Raf-1 Kinase Inhibitor Protein Expression Correlates with Breast Cancer Metastasis

Hagan, S., Al‐Mulla, F., Mallon, E., Oien, K. A., Ferrier, R., Gusterson, B. A., García, J. J. C., & Kölch, W. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0283 · Cited by 253 · see citing works

Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone

Clines, G. A., & Guise, T. A. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.00543 · Cited by 249 · see citing works

CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer

Righi, E., Kashiwagi, S., Yuan, J., Santosuosso, M., Leblanc, P. R., Ingraham, R., Forbes, B., Edelblute, B., Collette, B., Xing, D., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3143 · Cited by 246 · see citing works

CCR7 and CXCR4 as Novel Biomarkers Predicting Axillary Lymph Node Metastasis in T1 Breast Cancer

Cabıoğlu, N., Yazıcı, S., Arun, B., Broglio, K. R., Hortobágyi, G. N., Price, J. E., & Şahin, A. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0014 · Cited by 246 · see citing works

CXCL12/CXCR4 signaling activates Akt‐1 and MMP‐9 expression in prostate cancer cells: The role of bone microenvironment‐associated CXCL12

Chinni, S. R., Sivalogan, S., Dong, Z., Filho, J. C. T., Deng, X., Bonfil, R. D., & Cher, M. L. (2005) · The Prostate · doi:10.1002/pros.20318 · Cited by 246 · see citing works

Involvement of the Chemokine Receptor CXCR4 and Its Ligand Stromal Cell-Derived Factor 1α in Breast Cancer Cell Migration Through Human Brain Microvascular Endothelial Cells

Lee, B.-C., Lee, T.-H., Avraham, S., & Avraham, H. K. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.327.2.6 · Cited by 238 · see citing works

The Role of chemokine receptor CXCR4 in breast cancer metastasis.

Mukherjee, D., & Zhao, J. (2013) · Europe PMC (PubMed Central) · Cited by 237 · see citing works

Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti‐tumor mechanisms of Cannabidiol in breast cancer

Elbaz, M., Nasser, M. W., Ravi, J., Wani, N. A., Ahirwar, D. K., Zhao, H., Oghumu, S., Satoskar, A. R., Shilo, K., Carson, W. E., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2014.12.010 · Cited by 233 · see citing works

Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway

Ren, D., Yang, Q., Dai, Y., Guo, W., Du, H., Song, L., & Peng, X. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0688-6 · Cited by 234 · see citing works

Nuclear factor-κB: a friend or a foe in cancer?

Shishodia, S., & Aggarwal, B. B. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.04.026 · Cited by 228 · see citing works

NF-κB Signaling Pathway and Its Therapeutic Implications in Human Diseases

Sarkar, F. H., Li, Y., Wang, Z. P., & Kong, D. (2008) · International Reviews of Immunology · doi:10.1080/08830180802276179 · Cited by 227 · see citing works

Chronic circadian disruption modulates breast cancer stemness and immune microenvironment to drive metastasis in mice

Hadadi, É., Taylor, W. R., Li, X., Aslan, Y., Vilotte, M., Rivière, J., Duvallet, G., Auriau, C., Dulong, S., Raymond‐Letron, I., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16890-6 · Cited by 223 · see citing works

Telomere-independent Rap1 is an IKK adaptor and regulates NF-κB-dependent gene expression

Teo, H., Ghosh, S., Luesch, H., Ghosh, A., Wong, E. T., Malik, N. B. A., Orth, A. P., Jesus, P. D. D., Perry, A. S., Oliver, J. D., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2080 · Cited by 221 · see citing works

Endocrine Resistance in Hormone Receptor Positive Breast Cancer–From Mechanism to Therapy

Rani, A., Stebbing, J., Giamas, G., & Murphy, J. J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00245 · Cited by 219 · see citing works

Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer

Dewan, M. Z., Ahmed, S. M., Iwasaki, Y., Ohba, K., Toi, M., & Yamamoto, N. (2006) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2006.06.004 · Cited by 211 · see citing works

Up-regulation of CXCR4 Expression in PC-3 Cells by Stromal-Derived Factor-1α (CXCL12) Increases Endothelial Adhesion and Transendothelial Migration: Role of MEK/ERK Signaling Pathway–Dependent NF-κB Activation

Kukreja, P., Abdel‐Mageed, A. B., Mondal, D., Liu, K., & Agrawal, K. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1293 · Cited by 209 · see citing works

The chemokine network in cancer - much more than directing cell movement

Kulbe, H., Levinson, N. R., Balkwill, F. R., & Wilson, J. L. (2004) · The International Journal of Developmental Biology · doi:10.1387/ijdb.041814hk · Cited by 209 · see citing works

CXCR4 in breast cancer: oncogenic role and therapeutic targeting

Yao, Q., Xu, C., Zhao, H., & Chen, H. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s84932 · Cited by 208 · see citing works

Overexpression of Tissue Transglutaminase Leads to Constitutive Activation of Nuclear Factor-κB in Cancer Cells: Delineation of a Novel Pathway

Mann, A. P., Verma, A. K., Sethi, G., Manavathi, B., Wang, H., Fok, J. Y., Kunnumakkara, A. B., Kumar, R., Aggarwal, B. B., & Mehta, K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1457 · Cited by 205 · see citing works

The NF-κB/IκB signaling system: A molecular target in breast cancer therapy

Wu, J. T., & Kral, J. G. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2004.06.006 · Cited by 204 · see citing works

The Role of Immunoglobulin Superfamily Cell Adhesion Molecules in Cancer Metastasis

Wong, C.-W., Dye, D. E., & Coombe, D. R. (2012) · International Journal of Cell Biology · doi:10.1155/2012/340296 · Cited by 200 · see citing works

CXCR4 expression mediates glioma cell invasiveness

Ehtesham, M., Winston, J., Kabos, P., & Thompson, R. C. (2005) · Oncogene · doi:10.1038/sj.onc.1209302 · Cited by 198 · see citing works

NF-κB in cancer therapy

Li, F., Zhang, J., Arfuso, F., Chinnathambi, A., Zayed, M. E., Alharbi, S. A., Kumar, A. P., Ahn, K. S., & Sethi, G. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1470-4 · Cited by 198 · see citing works

Evidence for the Involvement of the Master Transcription Factor NF-κB in Cancer Initiation and Progression

Puar, Y., Shanmugam, M. K., Fan, L., Arfuso, F., Sethi, G., & Tergaonkar, V. (2018) · Biomedicines · doi:10.3390/biomedicines6030082 · Cited by 199 · see citing works

Cyr61 Expression Confers Resistance to Apoptosis in Breast Cancer MCF-7 Cells by a Mechanism of NF-κB-dependent XIAP Up-Regulation

Lin, M.-T., Chang, C.-C., Chen, S.-T., Chang, H.-L., Su, J.-L., Chau, Y.-P., & Kuo, M.-L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402305200 · Cited by 194 · see citing works

CXCR4 Expression Increases Liver and Lung Metastasis in a Mouse Model of Pancreatic Cancer

Saur, D., Seidler, B., Schneider, G., Algül, H., Beck, R., Senekowitsch–Schmidtke, R., Schwaiger, M., & Schmid, R. M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.06.056 · Cited by 186 · see citing works

Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma

Ebbing, E. A., van der Zalm, A. P., Steins, A., Creemers, A., Hermsen, S., Rentenaar, R., Klein, M., Waasdorp, C., Hooijer, G. K. J., Meijer, S. L., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820459116 · Cited by 183 · see citing works

Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2

Nagendraprabhu, P., & Sudhandiran, G. (2009) · Investigational New Drugs · doi:10.1007/s10637-009-9342-5 · Cited by 182 · see citing works

Chemokines: novel targets for breast cancer metastasis

Ali, S., & Lazennec, G. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9073-z · Cited by 180 · see citing works

Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer

Kang, H., Watkins, G., Parr, C., Douglas-Jones, A. G., Mansel, R. E., & Jiang, W. G. (2005) · Breast Cancer Research · doi:10.1186/bcr1022 · Cited by 178 · see citing works

Cancer Prevention with Promising Natural Products: Mechanisms of Action and Molecular Targets

Pratheeshkumar, P., Sreekala, C., Zhang, Z., Budhraja, A., Ding, S., Son, Y., Wang, X., Hitron, J. A., Hyun-Jung, K., Wang, L., et al. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012803833035 · Cited by 178 · see citing works

The monomer–dimer equilibrium of stromal cell‐derived factor‐1 (CXCL 12) is altered by pH, phosphate, sulfate, and heparin

Veldkamp, C. T., Peterson, F. C., Pelzek, A. J., & Volkman, B. F. (2005) · Protein Science · doi:10.1110/ps.041219505 · Cited by 175 · see citing works

Thymoquinone Inhibits Bone Metastasis of Breast Cancer Cells Through Abrogation of the CXCR4 Signaling Axis

Shanmugam, M. K., Ahn, K. S., Hsu, A., Woo, C. C., Yuan, Y., Tan, K. H. B., Chinnathambi, A., Alahmadi, T. A., Alharbi, S. A., Koh, A. P.-F., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01294 · Cited by 174 · see citing works

Emerging roles of the CXCL12/CXCR4 axis in pancreatic cancer progression and therapy

Sleightholm, R. L., Neilsen, B. K., Li, J., Steele, M. M., Singh, R. K., Hollingsworth, M. A., & Oupický, D. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.05.012 · Cited by 172 · see citing works

Epithelial-Mesenchymal Transition (EMT) as a Therapeutic Target

Jonckheere, S., Adams, J., Groote, D. D., Campbell, K., Berx, G., & Goossens, S. (2021) · Cells Tissues Organs · doi:10.1159/000512218 · Cited by 173 · see citing works

Circadian rhythm regulates the function of immune cells and participates in the development of tumors

Zeng, Y., Guo, Z., Wu, M., Chen, F., & Chen, L. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01960-1 · Cited by 184 · see citing works

Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4

Schimanski, C. C., Bahre, R., Gockel, I., Müller, W. E. G., Frerichs, K., Horner, V. L., Teufel, A., Simiantonaki, N., Biesterfeld, S., Wehler, T., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603251 · Cited by 168 · see citing works

CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy.

Mousavi, A. (2019) · Immunology Letters · doi:10.1016/j.imlet.2019.11.007 · Cited by 138 · see citing works

Glioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and Radioresistance

Fidoamore, A., Cristiano, L., Antonosante, A., d’Angelo, M., Giacomo, E. D., Astarita, C., Giordano, A., Ippoliti, R., Benedetti, E., & Cimini, A. (2016) · Stem Cells International · doi:10.1155/2016/6809105 · Cited by 164 · see citing works

Involvement of Chemokine Receptors in Organ-Specific Metastasis

Zlotnik, A. (2006) · KARGER eBooks · doi:10.1159/000092973 · Cited by 159 · see citing works

The sesquiterpene lactone parthenolide in combination with docetaxel reduces metastasis and improves survival in a xenograft model of breast cancer

Sweeney, C. J., Mehrotra, S., Sadaria, M. R., Kumar, S., Shortle, N. H., Roman, Y., Sheridan, C., Campbell, R. A., Murry, D. J., Badve, S., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0030 · Cited by 156 · see citing works

Trail induces cell migration and invasion in apoptosis-resistant cholangiocarcinoma cells

Ishimura, N., Isomoto, H., Bronk, S. F., & Gores, G. J. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00242.2005 · Cited by 155 · see citing works

The Inflammatory Cytokine Tumor Necrosis Factor-α Regulates Chemokine Receptor Expression on Ovarian Cancer Cells

Kulbe, H., Hagemann, T., Szlosarek, P. W., Balkwill, F. R., & Wilson, J. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0957 · Cited by 154 · see citing works

Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer

Cabıoğlu, N., Gong, Y. Y., Islam, R., Broglio, K. R., Sneige, N., Şahin, A. A., Gonzalez-Angulo, A. M., Morandi, P., BUCANA, C. D., Hortobágyi, G. N., et al. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm060 · Cited by 151 · see citing works

Anoikis and Survival Connections in the Tumor Microenvironment: Is There a Role in Prostate Cancer Metastasis?

Rennebeck, G., Martelli, M. G., & Kyprianou, N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2763 · Cited by 146 · see citing works

Telomerase Template Antagonist GRN163L Disrupts Telomere Maintenance, Tumor Growth, and Metastasis of Breast Cancer

Hochreiter, A. E., Xiao, H., Goldblatt, E. M., Gryaznov, S. M., Miller, K. D., Badve, S., Sledge, G. W., & Herbert, B.-S. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2760 · Cited by 146 · see citing works

Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies

Jorcyk, C. L., Tawara, K., & Jorcyk, C. L. (2011) · Cancer Management and Research · doi:10.2147/cmr.s18101 · Cited by 147 · see citing works

CXCR4-directed theranostics in oncology and inflammation

Kircher, M., Herhaus, P., Schottelius, M., Buck, A. K., Werner, R. A., Wester, H., Keller, U. B., & Lapa, C. (2018) · Annals of Nuclear Medicine · doi:10.1007/s12149-018-1290-8 · Cited by 144 · see citing works

Fatty acid-binding protein 5 (FABP5) promotes lipolysis of lipid droplets, de novo fatty acid (FA) synthesis and activation of nuclear factor-kappa B (NF-κB) signaling in cancer cells

Senga, S., Kobayashi, N., Kawaguchi, K., Ando, A., & Fujii, H. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.06.010 · Cited by 142 · see citing works

Antitumor activity and mechanism of costunolide and dehydrocostus lactone: Two natural sesquiterpene lactones from the Asteraceae family

Li, Q., Wang, Z., Xie, Y., & Hu, H. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109955 · Cited by 142 · see citing works

NF-κB in solid tumors

Pacifico, F., & Leonardi, A. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.032 · Cited by 143 · see citing works

Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-κB activation in breast and pancreatic tumor cells

Chua, A. W. L., Hay, H. S., Rajendran, P., Shanmugam, M. K., Li, F., Bist, P., Koay, E. S.-C., Lim, L. H. K., Kumar, A. P., & Sethi, G. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.045 · Cited by 140 · see citing works

Turmeric ( Curcuma longa ) inhibits inflammatory nuclear factor (NF)‐κB and NF‐κB‐regulated gene products and induces death receptors leading to suppressed proliferation, induced chemosensitization, and suppressed osteoclastogenesis

Kim, J. H., Gupta, S. C., Park, B., Yadav, V. R., & Aggarwal, B. B. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100270 · Cited by 141 · see citing works

Central Role of the Threonine Residue within the p+1 Loop of Receptor Tyrosine Kinase in STAT3 Constitutive Phosphorylation in Metastatic Cancer Cells

Yuan, Z., Guan, Y. A., Wang, L., Wei, W., Kane, A. B., & Chin, Y. E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9390-9400.2004 · Cited by 137 · see citing works

Involvement of the nuclear factor-κB signaling pathway in the regulation of CXC chemokine receptor-4 expression in neuroblastoma cells induced by tumor necrosis factor-α

Zhi, Y., Lu, H., Duan, Y., Sun, W.-S. W., Guan, G., Dong, Q., & Yang, C.-M. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.2032 · Cited by 47 · see citing works

NF-κB Signaling Pathway Confers Neuroblastoma Cells Migration and Invasion Ability via the Regulation of CXCR4

Yang, K. (2014) · Medical Science Monitor · doi:10.12659/msm.892597 · Cited by 32 · see citing works

NF-kB Signaling Pathway Confers Neuroblastoma Cells Migration and Invasion Ability via the Regulation of CXCR4

Zhi, B. Y., Duan, C. Y., Zhou, D. X., Yin, E. X., Guan, F. G., Zhang, G. H., Dong, A. Q., & Yang, F. K. (2016)

Up-regulation of CXCR4 Expression in PC-3 Cells by Stromal-Derived Factor-1α (CXCL12) Increases Endothelial Adhesion and Transendothelial Migration: Role of MEK/ERK Signaling Pathway–Dependent NF-κB Activation

Kukreja, P., Abdel‐Mageed, A. B., Mondal, D., Liu, K., & Agrawal, K. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1293 · Cited by 209 · see citing works

Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells.

Lee, B.-C., Lee, T.-H., Avraham, S., & Avraham, H. K. (2004) · PubMed · Cited by 281 · see citing works